Twenty-year survival following lung transplantation
Open accessThe DOI matches its Crossref record; 31 of the 34 references it cites were found in a registry or an index; none of the 9 sources its claims cite is checked for support yet.
Abstract
UNOS analysis of 6,172 recipients conditional on 1-year survival identifying factors associated with 20-year survival, including younger age, bilateral transplant, non-smoking donor, and diagnosis.
Overview
CoChat Summary
## TL;DR
In a UNOS cohort of 6,172 adult lung transplant recipients who survived the first post-transplant year, 472 (7.6%) lived 20 or more years. Long-term survival was more likely with younger recipient age, female-to-female matching, bilateral transplant, longer waitlist time, and lower HLA mismatch, and less likely with older age, COPD/emphysema, donor smoking, single-lung transplant, and poor renal function.
## Key findings
- Of 6,172 recipients analyzed, 472 (7.6%) survived 20+ years after lung transplantation.
- Factors associated with increased 20-year survival included female-to-female gender match, recipient age 25–44, waitlist time >1 year, HLA mismatch level 3, and donor cause of death by head trauma.
- Factors associated with decreased 20-year survival included recipient age ≥55, COPD/emphysema diagnosis, donor smoking history >20 pack-years, unilateral transplant, blood groups O&AB, recipient GFR <10 mL/min, and donor GFR 20–29 mL/min.
- In multivariable analysis, protective factors for 20+ year survival included recipient age 25–45 years (HR = 0.77–0.83), female-to-female matching (HR = 0.89), HLA mismatch level 3 (HR = 0.89), and waitlist time >1 year (HR = 0.79–0.90); risk factors included recipient age ≥55 years (HR = 1.24–1.51), COPD/emphysema (HR = 1.10), donor cigarette use (HR = 1.08), and single-lung transplant (HR = 1.30).
## Methods
- Retrospective analysis of the UNOS 2022 Thoracic Database; adult lung transplant recipients transplanted from October 16, 1987 to July 1, 2002 were included if they survived at least 1 year post-transplant.
- Final cohort: 6,172 adults after excluding multi-organ transplants (n=20), prior/subsequent transplants (n=595), and deaths within 1 year (n=2,084); 472 were 20+ year survivors.
- Main analysis used Kaplan-Meier survival analysis plus univariable and multivariable Cox regression for 20-year survival, repeated for 10-year survival; propensity score matching was used for sensitivity analyses on unilateral transplant and female-to-female matching.
## Limitations
- The authors state that the cohort was transplanted 20 years ago, and changes in immunosuppression, procurement, preservation, and transplant protocols limit generalizability to the contemporary era.
- The authors state that results may not be generalizable internationally because UNOS captures US transplants only, and registry data may have entry variability; cause of death may be subject to provider interpretation.
- The authors state that UNOS cannot measure quality of life, and that post-transplant events were not fully considered, although they restricted analysis to 1-year survivors to reduce confounding from early postoperative events.
- Evident from the text: this is an observational retrospective study, so associations cannot establish causation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 6 Not checked · 33 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Protective factors for 20+ year survival include recipient age 25–45 (HR =0.77–0.83), female-to-female gender matching (HR =0.89), HLA mismatch level 3 (HR =0.89), and waitlist time >1 year (HR =0.79–0.90).”
§ Twenty-year survival following lung transplantation > Results > Multivariable analysis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Still, 69% of our 20+ year survivors were not female-to-female”
§ Twenty-year survival following lung transplantation > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Protective factors for 20+ year survival include recipient age 25–45 (HR =0.77–0.83), female-to-female gender matching (HR =0.89), HLA mismatch level 3 (HR =0.89), and waitlist time >1 year (HR =0.79–0.90).”
§ Twenty-year survival following lung transplantation > Results > Multivariable analysis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Risk factors associated with death prior to 20 years after transplantation include recipient age ≥55 years [hazard ratio (HR) =1.24–1.51], recipient pretransplant diagnosis of COPD/E (HR =1.10), donor cigarette use (HR =1.08), and single lung transplant (HR =1.30), along with decreased donor and recipient GFR and short ischemic time.”
§ Twenty-year survival following lung transplantation > Results > Multivariable analysis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Risk factors associated with death prior to 20 years after transplantation include recipient age ≥55 years [hazard ratio (HR) =1.24–1.51], recipient pretransplant diagnosis of COPD/E (HR =1.10), donor cigarette use (HR =1.08), and single lung transplant (HR =1.30), along with decreased donor and recipient GFR and short ischemic time.”
§ Twenty-year survival following lung transplantation > Results > Multivariable analysis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 39 claims and every source verdict.
- It may state two separate claims as one. 6
- The quote only partly states this claim. 1
- Probably not a substantial claim. 1
Citations
Cites
Lung Homotransplantation in Man: Report of the Initial Case
Hardy, J. D., Webb, W. R., Dalton, M. L., & Walker, G. R. (1963) · JAMA · doi:10.1001/jama.1963.63710120001010 · Cited by 692
Chambers, D. C., Perch, M., Zuckermann, A., Cherikh, W. S., Harhay, M. O., Hayes, D., Hsich, E., Khush, K. K., Potena, L., Sadavarte, A., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.021 · Cited by 596 · cited 1×
“Importantly, advanced donor age was not associated with reduced likelihood of 10+ or 20+ year survival after controlling for other factors ( Tables 2,3 ).”
Survival in adult lung transplantation: where are we in 2020?
Bos, S., Vos, R., Van Raemdonck, D. E., & Verleden, G. M. (2020) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000753 · Cited by 281 · cited 1×
“Perhaps most relevant was the demonstration that bilateral recipients exhibit both milder symptoms and decreased incidence of bronchiolitis obliterans syndrome (BOS)—a prevalent subset of CLAD and a predominant cause of death in the late post-transplant period (18,19).”
Effect of the lung allocation score on lung transplantation in the United States
Egan, T. M., & Edwards, L. B. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.010 · Cited by 270 · cited 1×
“The most significant change that limits the generalizability of our results to a contemporary cohort is the LAS, which initiated allocation based on estimated urgency and utility rather than waitlist time (10).”
Technique of Successful Clinical Double-Lung Transplantation
Patterson, G. A., Cooper, J. D., Goldman, B., Weisel, R. D., Pearson, F. G., Waters, P. F., Todd, T. R., Scully, H., Goldberg, M., & Ginsberg, R. J. (1988) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)64763-7 · Cited by 255
OPTN/SRTR 2021 Annual Data Report: Lung
Valapour, M., Lehr, C. J., Schladt, D. P., Smith, J. M., Goff, R., Mupfudze, T. G., Swanner, K., Gauntt, K., & Snyder, J. J. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.02.009 · Cited by 194
OPTN/SRTR 2020 Annual Data Report: Heart
Colvin, M., Smith, J. M., Ahn, Y., Skeans, M. A., Messick, E., Bradbrook, K., Gauntt, K., Israni, A. K., Snyder, J. J., & Kasiske, B. L. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16977 · Cited by 190
Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion
Divithotawela, C., Cypel, M., Martinu, T., Singer, L. G., Binnie, M., Chow, C.-W., Chaparro, C., Waddell, T. K., de Perrot, M., Pierre, A., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.4079 · Cited by 171
Kulkarni, H. S., Cherikh, W. S., Chambers, D. C., Garcia, V. C., Hachem, R. R., Kreisel, D., Puri, V., Kozower, B. D., Byers, D. E., Witt, C. A., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.09.016 · Cited by 134
OPTN/SRTR 2020 Annual Data Report: Lung
Valapour, M., Lehr, C. J., Skeans, M. A., Smith, J. M., Miller, E., Goff, R. R., Mupfudze, T. G., Gauntt, K., & Snyder, J. J. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16991 · Cited by 132
Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study
Todd, J. L., Neely, M. L., Kopetskie, H., Sever, M. L., Kirchner, J., Frankel, C. W., Snyder, L. D., Pavlisko, E. N., Martinu, T., Tsuang, W. M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201910-1915oc · Cited by 89 · cited 1×
“A 2020 multicenter study even found that bilateral LTx specifically reduced acute rejection rates (17).”
Long-term outcomes and management of lung transplant recipients
Costa, J. A., Benvenuto, L. J., & Sonett, J. R. (2017) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2017.05.006 · Cited by 74
Tacrolimus Versus Cyclosporine for Adult Lung Transplant Recipients: A Meta-Analysis
Fan, Y., Xiao, Y.-B., & Weng, Y.-G. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.11.016 · Cited by 72 · cited 1×
“…controllable variable], bronchial anastomosis [1990], tacrolimus Food and Drug Administration approval [1994; survival comparable to cyclosporine (9)], implementing the Lung Allocation Score (LAS) [2005; slight survival increase (10)], inclusion of donation after cardiac death (DCD) donors…”
Bobba, C. M., Whitson, B. A., Henn, M. C., Mokadam, N. A., Keller, B. C., Rosenheck, J. P., & Ganapathi, A. M. (2022) · Transplant International · doi:10.3389/ti.2022.10172 · Cited by 59 · cited 1×
“…(LAS) [2005; slight survival increase (10)], inclusion of donation after cardiac death (DCD) donors [2012; outcomes on par with brain-dead donors (11)], and the recent advent of ex vivo lung perfusion (EVLP)—the factors that characterize those first few hundred to achieve 20 years of…”
Ghelichi-Ghojogh, M., Ghaem, H., Mohammadizadeh, F., Vali, M., Ahmed, F., Hassanipour, S., Nikbakht, H., Rezaei, F., & Fararouei, M. (2021) · Iranian Journal of Public Health · doi:10.18502/ijph.v50i8.6801 · Cited by 48
Weiss, E. S., Allen, J. G., Merlo, C. A., Conte, J. V., & Shah, A. S. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.06.027 · Cited by 46 · cited 1×
“For instance, Weiss et al. demonstrated a doubled 10-year survival rate among younger patients receiving bilateral LTx compared to unilateral (16).”
Loor, G., Brown, R. Z., Kelly, R. F., Rudser, K. D., Shumway, S. J., Cich, I., Holley, C. T., Quinlan, C., & Hertz, M. I. (2017) · Clinical Transplantation · doi:10.1111/ctr.12889 · Cited by 46 · cited 1×
“While our findings on recipient gender were consistent with prior observations favoring female recipients (23), the advantage for female-to-female donor-recipient matching was novel.”
Self-citationHistorical perspectives of lung transplantation: connecting the dots
Panchabhai, T. S., Chaddha, U., McCurry, K. R., Bremner, R. M., & Mehta, A. C. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.06 · Cited by 46
The role of innate immunity in the long-term outcome of lung transplantation
Kawashima, M., & Juvet, S. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.20 · Cited by 39 · cited 8×
“Our findings suggest areas for future investigation on the immunological roles that histocompatibility antigens, Y chromosome antigens, and carbon black from smoking may play in CLAD pathogenesis.”
InfluentialFactors associated with short- versus long-term survival after lung transplant
Jawitz, O. K., Raman, V., Becerra, D. C., Klapper, J. A., & Hartwig, M. G. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.09.097 · Cited by 38
Donor–recipient matching in lung transplantation: which variables are important?†
Demir, A., Coosemans, W., Decaluwé, H., Leyn, P. D., Nafteux, P. R., Veer, H. G. L. V., Verleden, G. M., & Raemdonck, D. E. V. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu340 · Cited by 34 · cited 1×
“Gender matching for LTx has been evaluated in the past with varying conclusions: a smaller study found no significant correlation (24), with a slightly larger study noting increased 5-year survival, indicating female-to-male mismatch as the strongest predictor of reduced survival (25).”
Influence of Gender Donor-Recipient Combinations on Survival After Human Lung Transplantation
Fessart, D., Dromer, C., Thumerel, M., Jougon, J. B., & Delom, F. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.08.101 · Cited by 30 · cited 1×
“Gender matching for LTx has been evaluated in the past with varying conclusions: a smaller study found no significant correlation (24), with a slightly larger study noting increased 5-year survival, indicating female-to-male mismatch as the strongest predictor of reduced survival (25).”
Impact of Cold Ischemia Time on Frequency of Airway Complications Among Lung Transplant Recipients
Nęcki, M., Antończyk, R., Pandel, A., Gawęda, M., Latos, M., Urlik, M., Stącel, T., Wajda-Pokrontka, M., Zawadzki, F., Przybyłowski, P., et al. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2020.03.047 · Cited by 27 · cited 1×
“Paradoxically, shorter cold ischemia time may appear to be a long-term risk factor; however ischemic time for double lungs reflects the mean value for both lungs, an important consideration for future UNOS studies (21).”
Current techniques and the future of lung preservation
Lautner, L. J., Freed, D. H., Nagendran, J., & Acker, J. P. (2020) · Cryobiology · doi:10.1016/j.cryobiol.2020.04.009 · Cited by 20 · cited 1×
“The demand for LTx continues to climb in the US (28), where cost per life-year gained is significantly higher than other solid organ transplants (29).”
Clinical implications of donor age: A single-institution analysis spanning 3 decades
Holley, C. T., Kelly, R. F., Shumway, S. J., Brown, R. Z., Hertz, M. I., Rudser, K. D., Quinlan, C. W., Cich, I., & Loor, G. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.06.029 · Cited by 17 · cited 1×
“This is consistent with a previous study showing lack of effect of donor age on 5-year survival (15).”
Self-citationLobar Lung Transplantation From Deceased Donor: Monocentric Experience
Mendogni, P., Palleschi, A., Tosi, D., Righi, I., Montoli, M., Damarco, F., Morlacchi, L. C., Santambrogio, L., Nosotti, M., & Rosso, L. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.02.020 · Cited by 13 · cited 1×
“Universal bilateral LTx would reduce the number of available organs for waitlisted patients and may only be feasible in regions where donor supply adequately satisfies demand (20).”
Sex Matters, But to What Clinical Avail?
Cowger, J. A., & Aaronson, K. D. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.902460 · Cited by 6 · cited 1×
“Transplanting an XX female donor into an XX female recipient eliminates the possibility of developing an immune response to Y chromosome antigens (26).”
Trends in marginal lung allograft survival: Advanced‐age donors improve
Miggins, J. J., Reul, R. M., Loor, G., Ferreira, L. D., Garcha, P., Goss, J. A., & Rana, A. A. (2022) · Clinical Transplantation · doi:10.1111/ctr.14777 · Cited by 6 · cited 2×
“Perhaps most significant is the drastic increase in proportion of bilateral LTx from about 40% to over 70%, which is likely to have the most optimistic impact on 20-year survival of today’s recipients (27).”
Self-citationWeiss, E. S., Allen, J. G., Merlo, C. A., Conte, J. V., & Shah, A. S. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.11.015 · Cited by 5
Allele-level HLA matching reduces early rejection in lung transplant recipients
Rajalingam, R. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.64 · Cited by 2
Donor Lung Allocation: Comment on “Lung Transplant in Idiopathic Pulmonary Fibrosis”
Kaiser, L. R. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.242 · Cited by 1
Cited by
Gouchoe, D. A., Cui, E. Y., Satija, D., Henn, M. C., Choi, K., Rosenheck, J. P., Nunley, D. R., Mokadam, N. A., Ganapathi, A. M., & Whitson, B. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154440 · Cited by 12
Moneke, I., Semmelmann, A., Ogutur, E. D., Şenbaklavacı, Ö., & Jungraithmayr, W. (2024) · Transplantation Proceedings · doi:10.1016/j.transproceed.2024.05.035 · Cited by 3
Beating the odds: long-term survival after lung transplantation
Salami, A., & Huddleston, S. J. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1018 · Cited by 1
“In a recent issue of Journal of Thoracic Disease , Miggins and colleagues report recipient and donor factors identified in the United Network for Organ Sharing (UNOS) database that are associated with long-term survival beyond 20 years of lung transplant conditional to one-year survival (1).”
BackgroundRighi, I., Fenizia, C., Trabattoni, D., Nosotti, M., Grisorio, G., Vanetti, C., Tella, S. D., Mocellin, C., Fantini, N. N., Prati, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1583460 · Cited by 1
Lung transplant imaging: What radiologists need to know
Soundararajan, P., & Ravi, B. (2025) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-025-01593-z · Cited by 1
Metadata
- Authors
- Miggins, J. J., Reul Jr, R. M., Barrett, S., Rana, A., Alnajar, A., Dunson, J., Shafii, A., Garcha, P., Goss, J., & Loor, G.
- Affiliations
- Baylor College of Medicine (US)
- University of Miami (US)
- Corresponding author
- Miggins, John James
- ORCID
- Venue
- Journal of Thoracic Disease
- Publisher
- AME Publishing Company
- Published
- 2023-06
- Volume
- 15
- Issue
- 6
- Pages
- 2997-3012
- ISSN
- 2072-1439 (ISSN-L)
- 2077-6624
- PMC
- PMC10323557
- OpenAlex
- W4382722379
- Cited by
- 8
- References
- 34
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Journal of Thoracic Disease (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- lung transplantation, long-term survival, risk factors, HLA mismatch, donor cause of death, chronic obstructive pulmonary disease, emphysema, glomerular filtration rate, donor age, waitlist time, gender matching, United Network for Organ Sharing registry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.